Lacosamide 16714-0552-01
- Manufacturer
- Northstar Rxllc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- August 1, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA208308
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 200 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
16714-0552-01Selected60 TABLET in 1 BOTTLE (16714-552-01)